%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2019-02-28T11:59:58+01:00
2019-02-28T12:00:02+01:00
2019-02-28T12:00:02+01:00
Adobe InDesign CC 14.0 (Macintosh)
uuid:93c73ce7-b9d5-a847-9d12-75c8ee61a49e
xmp.did:ae6c1fa0-7850-489d-add4-d83f4f23f1d8
xmp.id:c51afac6-3d74-4b65-8396-532bc07fed2b
proof:pdf
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 14.0 (Macintosh)
/
2019-02-28T11:59:58+01:00
xmp.iid:8971aad6-2383-457a-824e-2ee1f8abee5e
xmp.did:ae6c1fa0-7850-489d-add4-d83f4f23f1d8
xmp.did:ae6c1fa0-7850-489d-add4-d83f4f23f1d8
default
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
3 0 obj
<>
endobj
5 0 obj
</LastModified/NumberofPages 1/OriginalDocumentID/PageUIDList<0 838>>/PageWidthList<0 841.89>>>>>>/Resources<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/Shading<>/XObject<>>>/TrimBox[0.0 0.0 841.89 595.276]/Type/Page>>
endobj
6 0 obj
</LastModified/NumberofPages 1/OriginalDocumentID/PageUIDList<0 1233>>/PageWidthList<0 841.89>>>>>>/Resources<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/TrimBox[0.0 0.0 841.89 595.276]/Type/Page>>
endobj
39 0 obj
<>stream
q
0 0 841.89 595.276 re
W n
q
/GS0 gs
0 TL/Fm0 Do
Q
q
/GS1 gs
0 TL/Fm1 Do
Q
q
/GS2 gs
0 TL/Fm2 Do
Q
Q
0 0 0 0 k
/GS3 gs
q
2.605 0 0 -2.5774825 420.9448853 297.6377869 cm
-157.238 -111.077 57.136 48.918 re
f
Q
q
11.337 581.337 148.838 -123.484 re
W n
q
170.6338688 0 0 126.8245326 -3.6119385 454.5123815 cm
/Im0 Do
Q
Q
0 0.6 0.6 0.12 k
161.575 549.625 657.638 3.131 re
f
BT
1 0 1 0.3 k
/T1_0 1 Tf
-0.019 Tc 0.019 Tw 9 0 0 9 161.5748 559.9271 Tm
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA )Tj
1 0 1 0.3 k
/T1_0 1 Tf
7.309 0 Td
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA )Tj
1 0 1 0.3 k
/T1_0 1 Tf
7.309 0 Td
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA )Tj
1 0 1 0.3 k
/T1_0 1 Tf
7.309 0 Td
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA )Tj
1 0 1 0.3 k
/T1_0 1 Tf
7.309 0 Td
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA )Tj
1 0 1 0.3 k
/T1_0 1 Tf
7.309 0 Td
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA )Tj
1 0 1 0.3 k
/T1_0 1 Tf
7.309 0 Td
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA )Tj
1 0 1 0.3 k
/T1_0 1 Tf
7.309 0 Td
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA )Tj
1 0 1 0.3 k
/T1_0 1 Tf
7.309 0 Td
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA )Tj
1 0 1 0.3 k
/T1_0 1 Tf
7.309 0 Td
(GLAUCO)Tj
0 1 1 0.2 k
/T1_1 1 Tf
(RETINA)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
0 Tc 0 Tw 9.9 0 0 11 172.9134 515.1078 Tm
(8.00)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
2.175 Tw /Span<>> BDC
11 0 0 11 194.1192 515.1078 Tm
( )Tj
EMC
(Registrazione)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
0 Tw 9.9 0 0 11 172.9134 489.9078 Tm
(8.30)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 194.1192 489.9078 Tm
( )Tj
EMC
2.453 0 Td
(Introduzione ai lavori)Tj
0 0.9 0.9 0.18 k
-0.01 Tc 0 -1.2 Td
[(L. Zompatori)-10 ( )]TJ
0.8 0 0.8 0.24 k
/T1_2 1 Tf
0 Tc 13 0 0 13 143.8219 438.9078 Tm
(I SESSIONE - RETINA)Tj
0 0 0 0.9 k
/T1_0 1 Tf
11 0 0 11 22.6772 405.2038 Tm
(Moderatori: )Tj
0 0.9 0.9 0.18 k
/T1_1 1 Tf
(L. Zompatori, R. Giannini, S. Zenoni)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 22.6772 380.0038 Tm
(9.00)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
-0.118 Tw 11 0 0 11 43.8829 380.0038 Tm
( )Tj
/Span<>> BDC
0.278 0 Td
( )Tj
EMC
2.433 0 Td
(Angio OCT patterns a lungo termine della risposta al trattamento )Tj
0 Tw 0 -1.145 Td
(delle CNV ed aspetti delle recidive - )Tj
0 0.9 0.9 0.18 k
(M. Rispoli)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 22.6772 342.2039 Tm
(9.10)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 43.8829 342.2039 Tm
( )Tj
EMC
2.711 0 Td
(Corioretinite sierosa centrale: nuove prospettive terapeutiche)Tj
0 0.9 0.9 0.18 k
0 -1.145 Td
(M.C. Savastano)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 22.6772 304.4038 Tm
(9.20)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
0.016 Tw /Span<>> BDC
11 0 0 11 43.8829 304.4038 Tm
( )Tj
EMC
2.711 0 Td
[(Nuovi )0.6 (percorsi )0.5 (nel )0.6 (trattamento )0.6 (delle )0.5 (maculopatie: )0.5 (esperienze )0.6 (a )]TJ
0 Tw 0 -1.145 Td
(confronto)Tj
0 0.8 0.8 0.16 k
( - )Tj
0 0.9 0.9 0.18 k
-0.01 Tc (R. Appolloni, G. Colacino, M. Schiavone)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
0 Tc 9.9 0 0 11 22.6772 266.6038 Tm
(9.50)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
2.433 Tw /Span<>> BDC
11 0 0 11 43.8829 266.6038 Tm
( )Tj
EMC
(Discussione)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
0 Tw 9.9 0 0 11 22.6772 241.4038 Tm
(10.00)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 49.9417 241.4038 Tm
( )Tj
EMC
1 0 1 0.3 k
/T1_3 1 Tf
2.16 0 Td
[(Pausa caf)17.9 (f\350)]TJ
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 22.6772 216.2038 Tm
(10.30)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 49.9417 216.2038 Tm
( )Tj
EMC
/T1_2 1 Tf
0.054 Tw 2.16 0 Td
[(T)98.9 (avola )0.6 (Rotonda: )]TJ
1 0 1 0.3 k
/T1_0 1 Tf
0.049 Tw 8.71 0 Td
[(Casi )0.5 (clinici e )0.5 (chirurgici )0.5 (nel trattamento delle )]TJ
0 Tw -8.71 -1.145 Td
[(patologie r)17.9 (etiniche e maculari)]TJ
0 0 0 0.8 k
/T1_1 1 Tf
/Span<>> BDC
-4.639 -1.145 Td
( )Tj
EMC
4.639 0 Td
(La chirurgia della DMS nell\222era anti VEGF - )Tj
0 0.9 0.9 0.18 k
(C. Mariotti)Tj
0 0 0 0.8 k
0 -1.145 Td
(Danni iatrogeni nella chirurgia maculare - )Tj
0 0.9 0.9 0.18 k
(L. Zompatori)Tj
0 0 0 0.9 k
/T1_0 1 Tf
0 -2.291 Td
(Responsabile scienti\037co: )Tj
0 0.9 0.9 0.18 k
/T1_1 1 Tf
(R. Giannini)Tj
0 0 0 0.9 k
/T1_0 1 Tf
0 -1.145 Td
[(Pr)17.8 (esidente: )]TJ
0 0.9 0.9 0.18 k
/T1_1 1 Tf
(C. Azzolini)Tj
0 0 0 0.9 k
/T1_0 1 Tf
0 -1.145 Td
[(Pr)17.8 (esentazione casi chirurgici: )]TJ
0 0.9 0.9 0.18 k
/T1_1 1 Tf
(M. Romano)Tj
0 0 0 0.9 k
/T1_0 1 Tf
0 -1.145 Td
(Panelisti: )Tj
0 0.9 0.9 0.18 k
/T1_1 1 Tf
(G. Besozzi, B. Billi, C. Mariotti, M. Marullo, )Tj
0 -1.2 Td
[(C. T)74 (amburrelli)]TJ
(, S. Zenoni, L. Zompatori)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 22.6772 89.0038 Tm
(12.30)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
1.882 Tw /Span<>> BDC
11 0 0 11 49.9417 89.0038 Tm
( )Tj
EMC
(Discussione)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
0 Tw 9.9 0 0 11 22.6772 62.6038 Tm
(12.50)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
-0.01 Tc -0.01 Tw /Span<>> BDC
11 0 0 11 49.9417 62.6038 Tm
( )Tj
EMC
2.16 0 Td
(Presentazione CBM \(Christian Blind Mission\) Italia ONG - )Tj
0 0.9 0.9 0.18 k
(M. Angi)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
0 Tc 0 Tw 9.9 0 0 11 22.6772 37.4038 Tm
(13.00)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 49.9417 37.4038 Tm
( )Tj
EMC
1 0 1 0.3 k
/T1_3 1 Tf
2.16 0 Td
(Pausa pranzo)Tj
0.8 0 0.8 0.24 k
/T1_2 1 Tf
13 0 0 13 547.4313 513.5518 Tm
(II S)Tj
(ESSIONE - GLAUCOMA)Tj
0 0 0 0.9 k
/T1_0 1 Tf
11 0 0 11 443.6221 479.8478 Tm
(Moderatori: )Tj
0 0.9 0.9 0.18 k
/T1_1 1 Tf
(L. Zompatori, L. Zeppa, R. Giannini, A. Mauro)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 443.622 454.6478 Tm
(14.00)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
-0.02 Tc -0.093 Tw /Span<>> BDC
11 0 0 11 470.8865 454.6478 Tm
( )Tj
EMC
2.16 0 Td
(La super\037cie oculare nel trattamento a lungo termine del glaucoma)Tj
0 0.9 0.9 0.18 k
0 Tc 0 Tw 0 -1.2 Td
(E. Cantera)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 443.622 416.2478 Tm
(14.10)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 470.8865 416.2478 Tm
( )Tj
EMC
2.16 0 Td
(Quadri campimetrici ed aspetti papillari corrispondenti. )Tj
( )Tj
0 -1.2 Td
(Quiz Interattivi - )Tj
0 0.9 0.9 0.18 k
(M. Schiavone)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 443.6221 377.2478 Tm
(14.40)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 470.8866 377.2478 Tm
( )Tj
EMC
2.16 0 Td
[(Neuroprotezione: dif)17.9 (ferenti strategie a confronto - )]TJ
0 0.9 0.9 0.18 k
(C. Nucci)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 443.622 352.0479 Tm
(15.00)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 470.8865 352.0479 Tm
( )Tj
EMC
2.16 0 Td
(Il Glaucoma a bassa pressione: un ossimoro in oftalmologia)Tj
0 0.9 0.9 0.18 k
0 -1.2 Td
(C. Costagliola)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 443.622 313.0479 Tm
(15.20)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 470.8865 313.0479 Tm
( )Tj
EMC
2.16 0 Td
(Il glaucoma ad angolo stretto - )Tj
0 0.9 0.9 0.18 k
(A. Petrone)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 443.6221 287.2478 Tm
(15.30)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 470.8866 287.2478 Tm
( )Tj
EMC
/T1_2 1 Tf
2.16 0 Td
[(T)98.9 (avola Rotonda: )]TJ
1 0 1 0.3 k
/T1_0 1 Tf
(Casi clinici e chirurgici nella patologia )Tj
0 -1.2 Td
(glaucomatosa)Tj
0 0 0 0.9 k
/Span<>> BDC
-4.639 -1.2 Td
( )Tj
EMC
/T1_1 1 Tf
4.639 0 Td
(Introduzione -)Tj
0 0.9 0.9 0.18 k
( )Tj
(R. Giannini)Tj
/Span<>> BDC
-4.639 -1.2 Td
( )Tj
EMC
0 0 0 0.9 k
/T1_0 1 Tf
4.639 0 Td
[(Pr)17.8 (esidente:)]TJ
0 0.9 0.9 0.18 k
/T1_1 1 Tf
( A. Caporossi)Tj
0 0 0 0.9 k
/T1_0 1 Tf
4.361 Tw /Span<>> BDC
-4.638 -1.2 Td
( )Tj
EMC
4.639 0 Td
(Moderatori:)Tj
0 0.9 0.9 0.18 k
/T1_1 1 Tf
0 Tw ( L. Zompatori, R. Giannini, C. Costagliola)Tj
0 0 0 0.9 k
/T1_0 1 Tf
4.361 Tw /Span<>> BDC
-4.639 -1.2 Td
( )Tj
EMC
4.639 0 Td
(Panelisti: )Tj
0 0.9 0.9 0.18 k
/T1_1 1 Tf
0 Tw 4.502 0 Td
[(G. Ghirelli, M. Giuliano, P)129 (. Quercioli, E. Scerrati, )]TJ
( )Tj
-4.502 -1.2 Td
(M. Schiavone, L. Zeppa)Tj
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 443.622 182.8478 Tm
(17.30)Tj
0 0 0 0.8 k
/GS3 gs
/T1_1 1 Tf
/Span<>> BDC
11 0 0 11 470.8865 182.8478 Tm
( )Tj
EMC
/T1_3 1 Tf
2.16 0 Td
[(T)74 (est di veri\037ca di apprendimento)]TJ
0 0 0 1 k
/GS4 gs
/T1_2 1 Tf
9.9 0 0 11 443.622 170.2478 Tm
(17.45)Tj
ET
0 0.2 0.2 0.04 k
/GS3 gs
432.283 17.823 386.929 137.374 re
f
BT
0.8 0 0.8 0.24 k
/T1_0 1 Tf
-0.01 Tc 0.01 Tw 11 0 0 11 642.5941 141.8629 Tm
(ECM)Tj
0 0 0 1 k
/GS4 gs
/T1_1 1 Tf
0.021 Tw 10 0 0 10 494.6457 130.8629 Tm
[(L)91.8 (\222evento \350 stato accreditato per 100 partecipanti.)]TJ
/T1_4 1 Tf
0 Tc 0 Tw ( )Tj
/T1_1 1 Tf
-0.01 Tc 0.021 Tw 22.776 0 Td
(Il rilascio della certi)Tj
0 Tc 0 Tw (-)Tj
-0.01 Tc 0.041 Tw -22.776 -1.1 Td
[(\037cazione dei crediti \350 subordinato alla partecipazione ef)17.8 (fettiva all\222in)]TJ
0 Tc 0 Tw (-)Tj
-0.01 Tc 0.022 Tw 0 -1.1 Td
(tero programma formativo ed al superamento del questionario di ve)Tj
0 Tc 0 Tw (-)Tj
-0.01 Tc 0 -1.1 Td
(ri\037ca dell\222apprendimento.)Tj
/T1_0 1 Tf
0 -2.2 Td
[(Rif. ECM 806 248703)-10 ( )]TJ
0.285 Tw 0 -1.1 Td
(Obiettivo formativo:)Tj
/T1_1 1 Tf
[( contenuti tecnico-professionali \(conoscenze e)-10 ( )]TJ
0.058 Tw 0 -1.1 Td
(competenze\) speci\037ci di ciascuna professione, di ciascuna specializz\
a)Tj
0 Tc 0 Tw (-)Tj
-0.01 Tc 0 -1.1 Td
(zione e di ciascuna attivit\340 ultraspecialistica. Malattie rare.)Tj
/T1_0 1 Tf
-0.008 Tw 0 -1.1 Td
[(Figur)17.9 (e pr)17.9 (ofessionali:)]TJ
/T1_1 1 Tf
0 Tc 0 Tw ( )Tj
/T1_3 1 Tf
-0.01 Tc -0.008 Tw 9.563 0 Td
(medici specialisti in oftalmologia, ortottisti ed in)Tj
0 Tc 0 Tw (-)Tj
-0.01 Tc 0.01 Tw -9.563 -1.1 Td
(fermieri)Tj
ET
q
426.662 117.268 m
446.16 71.335 l
498.998 93.764 l
479.501 139.697 l
h
W n
q
/GS3 gs
52.8384307 22.4285801 -19.4975745 45.9334094 446.1598975 71.3350995 cm
/Im1 Do
Q
Q
BT
0 1 1 0.2 k
/GS3 gs
/TT0 1 Tf
0 Tc 0 Tw 12 0 0 12 441.3898 62.1908 Tm
(7 crediti )Tj
-0.209 -1.2 Td
(formativi)Tj
ET
endstream
endobj
40 0 obj
<>
endobj
47 0 obj
<>>>/Subtype/Form>>stream
0.3 0 0.3 0.09 k
/GS0 gs
432.284 474.095 51.024 -309.685 re
f
endstream
endobj
48 0 obj
<>>>/Subtype/Form>>stream
0.3 0 0.3 0.09 k
/GS0 gs
11.339 396.85 51.024 -377.008 re
f
endstream
endobj
49 0 obj
<>>>/Subtype/Form>>stream
0 0.2 0.2 0.04 k
/GS0 gs
161.575 532.913 238.11 -65.197 re
f
endstream
endobj
50 0 obj
<>stream
Adobe d
!1"ABQa Rbq
#$%&'()*23456789:CDEFGHIJSTUVWXYZcdefghijrstuvwxyz I9 !1"AQa2q #$3r
%&'()*456789:BCDEFGHIJRSTUVWXYZbcdefghijstuvwxyz𘙚 ? Bʥ BR!H BR!H BR!H B6^T{il,쑎oVf7)4juBquB()B 1!
x1"5KFלlŊFhIp-֣2GvL3wd͘Q X@4DE Q&_2!"%pL0^_Z^62;qE<Yà{Z1;5s6nZKyR Q739PeˊN ARA^7E/hKGcڭ,UG-jq17 Nht#Zf>+RR!H BR!H BR!H B Bʥ BR!H BR!H BR!cjK]HNg3].AbMVt@Yn@TBs?$VmbZM7$пAimKL9Қ@VjN4mifldHqI(;p'M ߥ!C